Spinal Stenosis Clinical Trial
— IVANOSOfficial title:
The Clinical Effect of i-FACTOR® Versus Allograft in Non-instrumented Posterolateral Spondylodesis Operation
Verified date | September 2016 |
Source | Sygehus Lillebaelt |
Contact | n/a |
Is FDA regulated | No |
Health authority | DK: Ethics committee |
Study type | Interventional |
The average life expectancy in Denmark is increasing resulting in an increasing part of the
population having age-related disease, ex lumbar spinal stenosis (LSS). LSS causes
constriction of the nerves in the lumbar spine resulting in pain in the legs and lower back,
especially when standing and walking, known as neurogenic claudication(Goh KJ FAU - Khalifa
et al.). LSS occurs in a combination of degenerative changes in the lower back, including
hypertrophy of the ligamentum flavus, arthrosis of the facet joints and bulging of the disc.
Current treatment of LSS is varied ranging from non-operative conservative treatment to
operation.
Operative intervention shows very good results according to physical ability and
pain(Christensen FB et al.;Hee HT and Wong;McGregor AH FAU - Hughes and Hughes;Xu et al.),
but the most optimal treatment is still debated. Nevertheless, a decompression and, if
needed, a spinal fusion is recommended.(Ausman).
Clinical improvement including decrease of pain, improved ADL-function and an increased
quality of life are parameters of highest interest and the purpose of an operation is clear:
Making sufficient room for the affected nerves. In addition fusion is desired achieving
stability avoiding a new compression of the nerves. Studies attending these issues find a
correlation between fusion and clinical outcome, why obtained fusion of the affected levels
are very important(Andersen et al.;Andersen et al.;Girardo et al.;Kornblum MB FAU -
Fischgrund et al.).
P-15, bound to Anorganisk Bone Mineral (ABM), called i-FACTOR®, shows fusion superiority, no
side effects and no risk of transferring disease(Thorwarth et al. 5648-57;Thorwarth et al.
789-95;Wenz, Oesch, and Horst 1599-606;Scarano et al. 318-24;Kubler et al. 171-79) why the
investigators find this material suited for fusion surgery in the elderly.
To the investigators knowledge this is the first prospective study comparing fusion rates
and postoperative clinic with i-FACTOR vs allograft in older patients operated with
decompression and spondylodesis because of spinal stenosis due to degenerative
spondylolisthesis.
Hypothesis:
There are no difference in the clinical parameters measured by ODI and fusion rates
comparing i-FACTOR® and allograft in non-instrumented posterolateral
spondylodesis-operations in patients 60 years and older.
Status | Active, not recruiting |
Enrollment | 108 |
Est. completion date | May 2018 |
Est. primary completion date | June 2013 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 60 Years and older |
Eligibility |
Inclusion Criteria: - Spinal stenosis, olisthesis grade 1-2 (>3 mm), facet joint arthrosis and flavus hypertrophia verified by a mr-scan and x-ray including maximally 2 levels ranging from L1-S1. - A score of 6 and more on Konno´s "History of Examination Characteristic". - Signed informed content. Exclusion Criteria: - Any disease demanding obligate thromboprophylaxis treatment, including mechanical valve, (DVT with cancer/thrombophilia, AMI, apoplexia cerebri, TCI, valve-operation)< 3 months, coronar metal stent < 6 weeks and coronar drug eluted/coated stent < 12 months. - Atrial fibrillation and one of the following: Mitral stenosis, valveprothesis and apoplexia cerebri/TCI. - Atrial fibrillation and two of the following: Heart insufficient, HT, DM, age > 75 years, EF < 35 %. - Known cancer in the axial skeleton. - Ongoing chemotherapy. - Fracture i the lower back within a year prior to inclusion. - Reduced distance of walking due to non-spinal related causes. - Candidate for more than two-level intervention. - Dementia assessed by the MMSE - ASA 3+4 - Age below 60 years. - Missed 3 months of conservative treatment without success - The use of steroids and bisphosphonates. - Prior radiotherapy to the lower back. - Haematologic disease. |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
Denmark | Rygkirurgisk sektor Middelfart | Middelfart | Region syddanmark |
Denmark | Sygehuslillebaelt | Middelfart | DK |
Lead Sponsor | Collaborator |
---|---|
Sygehus Lillebaelt | CeraPedics, Inc |
Denmark,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | The clinical effect of i-FACTOR® versus allograft in non-instrumented posterolateral spondylodesis operation in the elderly with spinal stenosis due to degenerative spondylolisthesis measured by ODI | 24 months postoperative | No | |
Secondary | The clinical effect of i-FACTOR® versus allograft in non-instrumented posterolateral spondylodesis operation in the elderly with spinal stenosis due to degenerative spondylolisthesis assessed by fusion rates | 12 months postoperative | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT06290908 -
RPE-P/TLIF for Lumbar Spinal Stenosis With Instability
|
||
Withdrawn |
NCT03223701 -
Efficacy of Using Solum IV and BMC With GFC in TLIF
|
Phase 4 | |
Recruiting |
NCT03883022 -
Vancomycin Powder Combined With Autogenous Bone Graft as a Prevention for Post-operative Infection for Spine Surgery
|
N/A | |
Completed |
NCT02902380 -
The Effect of Dexmedetomidine on Neuroendocrine Stress Hormone Release and Heart Rate Variability in Patients Undergoing Major Spinal Surgery
|
N/A | |
Not yet recruiting |
NCT06024785 -
Vertebropexy - Randomized-controlled Trial
|
N/A | |
Not yet recruiting |
NCT06000319 -
Natural Matrix Protein™ (NMP™) Fibers in Cervical and Lumbar Interbody Fusion
|
||
Completed |
NCT02558621 -
New Robotic Assistance System for Spinal Fusion Surgery
|
N/A | |
Completed |
NCT02454400 -
Pre-surgery Physiotherapy for Patients With Specific Low Back Pain
|
N/A | |
Completed |
NCT01377623 -
Pilot Study on the Effect of Dexmedetomidine on Inflammatory Responses in Patients Undergoing Lumbar Spinal Fusion
|
N/A | |
Terminated |
NCT00974623 -
Bone Graft Materials Observational Registry
|
N/A | |
Completed |
NCT00996073 -
Safety and Preliminary Efficacy Study of NeoFuse in Subjects Requiring Lumbar Interbody Fusion
|
Phase 2 | |
Completed |
NCT00022776 -
Surgical Versus Nonsurgical Treatment for Spinal Stenosis
|
Phase 3 | |
Completed |
NCT00320619 -
Epsilon-Aminocaproaic Acid to Reduce the Need for Blood Transfusions During and Following Spine Surgery
|
N/A | |
Completed |
NCT06060821 -
Validity and Reliability of the 2-minute Step Test in Patients With Lumbar Spinal Stenosis
|
||
Recruiting |
NCT04552145 -
Physical Therapy vs Surgical Decompression for Lumbar Spinal Stenosis
|
N/A | |
Active, not recruiting |
NCT04379921 -
Improving Spine Surgical Care With Real-Time Objective Patient Tracking Using the Apple Watch
|
N/A | |
Withdrawn |
NCT04315090 -
Post-surgical Outcomes Measure Using the ERAS Protocol for Posterior Cervical Decompression and Fusion
|
||
Completed |
NCT04591249 -
Physical Activity Intervention for Patients Following Lumbar Spine Surgery
|
N/A | |
Recruiting |
NCT04601363 -
Personalized Spine Study Group (PSSG) Registry
|
||
Completed |
NCT04193488 -
Mid-Transverse Process to Pleural (MTP) Block and Erector Spinal Plan (ESP) Block in Spinal Surgery
|
N/A |